New Search

Your search found 5 records, sorted newest to oldest.

1. Buprenorphine Tapering Schedule and Illicit Opioid Use. doc type
  Ling, Walter ; Hillhouse, Maureen ; Domier, Catherine ; Doraimani, Geetha ; Hunter, Jeremy ; Thomas, Christie ; Jenkins, Jessica ; Hasson, Albert ; Annon, Jeffrey J. ; Saxon, Andrew J. ; Selzer, Jeffrey A. ; Boverman, Joshua ; Bilangi, Richard
  Addiction 2009;104(2):256-265 [doi: 10.1111/j.1360-0443.2008.02455.x].
 
2. Standardized Patients as Participants in Clinical Trials Protocol Implementation. doc type
  Fussell, Holly E. ; Kunkel, Lynn E. ; Shannon-Lewy, Colleen ; McFarland, Bentson H.
  Poster presented at the NIDA Blending Conference, "Blending Addiction Science & Practice: Bridges to the Future," Seattle, WA, October 16-17, 2006.
 
3. Using Standardized Patients to Pilot Screening Visits in Clinical Trials. doc type
  Kunkel, Lynn E. ; Fussell, Holly E. ; Shannon-Lewy, Colleen ; McFarland, Bentson H.
  Poster presented at the Society for Clinical Trials Annual Meeting, Montreal, Canada, May 20-23, 2007.
 
4. Smoking Cessation Study for Smokers with Attention Deficit Hyperactivity Disorder (ADHD): Should I Participate? doc type
  NIDA Center for the Clinical Trials Network (NIDA CCTN)
 
 
5. Suboxone (Buprenorphine/Naloxone) Taper: A Comparison of Taper Schedules. Should I Join? doc type
  NIDA Center for the Clinical Trials Network (NIDA CCTN)
 
 

New Search